Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Sitravatinib |
Trade Name | |
Synonyms | MGCD516 |
Drug Descriptions |
Sitravatinib (MGCD516) inhibits several receptor tyrosine kinases including AXL, MET, KIT, VEGFR1-3, TYRO3, RET family members, TRK family members, DDR, and Eph family members, resulting in abrogation of downstream signaling and decreased cell proliferation in tumors overexpressing the target proteins (PMID: 26675259, PMID: 30501104, PMID: 32525624). |
DrugClasses | AXL Inhibitor 30 DDR1 Inhibitor 10 DDR2 inhibitor 7 KIT Inhibitor 57 MERTK Inhibitor 13 MET Inhibitor 59 RET Inhibitor 53 Trk Receptor Inhibitor (Pan) 32 TYRO3 Inhibitor 8 VEGFR Inhibitor (Pan) 36 |
CAS Registry Number | 1123837-84-2 |
NCIT ID | C117734 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Docetaxel + Sitravatinib | Docetaxel Sitravatinib | 0 | 0 |
Enfortumab vedotin-ejfv + Sitravatinib | Enfortumab vedotin-ejfv Sitravatinib | 0 | 1 |
Ipilimumab + Nivolumab + Sitravatinib | Ipilimumab Nivolumab Sitravatinib | 0 | 1 |
Ipilimumab + Sitravatinib | Ipilimumab Sitravatinib | 0 | 1 |
Nivolumab + Sitravatinib | Nivolumab Sitravatinib | 0 | 8 |
Pembrolizumab + Sitravatinib | Pembrolizumab Sitravatinib | 0 | 3 |
Sitravatinib | Sitravatinib | 7 | 4 |
Sitravatinib + Tislelizumab | Sitravatinib Tislelizumab | 0 | 2 |